Lipid changes in Kenyan HIV-1-infected infants initiating highly active antiretroviral therapy by 1 year of age

about

Dyslipidemia, Diet and Physical Exercise in Children on Treatment With Antiretroviral Medication in El Salvador: A Cross-sectional Study Changes in elevated cholesterol in the era of tenofovir in South Africa: risk factors, clinical management and outcomes.

P2860

Q28395417-8B124525-ABFB-4F34-B277-A3C8B9141BB0 Q40278973-9F3B7912-68A5-4314-BCB6-0D7035DFC2B0

P2860

Lipid changes in Kenyan HIV-1-infected infants initiating highly active antiretroviral therapy by 1 year of age

Item

http://www.wikidata.org/entity/Q37080086

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Lipid changes in Kenyan HIV-1- ...... viral therapy by 1 year of age

@en

Lipid changes in Kenyan HIV-1- ...... iral therapy by 1 year of age.

@nl

type

Item

label

Lipid changes in Kenyan HIV-1- ...... viral therapy by 1 year of age

@en

Lipid changes in Kenyan HIV-1- ...... iral therapy by 1 year of age.

@nl

prefLabel

Lipid changes in Kenyan HIV-1- ...... viral therapy by 1 year of age

@en

Lipid changes in Kenyan HIV-1- ...... iral therapy by 1 year of age.

@nl

P1476

Lipid changes in Kenyan HIV-1- ...... viral therapy by 1 year of age

@en

P2093

Agnes Langat

http://www.w3.org/2001/XMLSchema#string

Ann Melvin

http://www.w3.org/2001/XMLSchema#string

Barbra A Richardson

http://www.w3.org/2001/XMLSchema#string

Evelyn Ngugi

http://www.w3.org/2001/XMLSchema#string

Grace C John-Stewart

http://www.w3.org/2001/XMLSchema#string

Lara Diener

http://www.w3.org/2001/XMLSchema#string

P2860

Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS

Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.

Early antiretroviral therapy and mortality among HIV-infected infants

Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.

Metabolic complications of antiretroviral therapy in children.

Fasting might not be necessary before lipid screening: a nationally representative cross-sectional study.

Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.

Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapy.

Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.

Survival benefit of early infant antiretroviral therapy is compromised when diagnosis is delayed.

P304

e298-304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/INF.0B013E31828AFB2A

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sarah Benki-Nugent

Dalton Wamalwa

Kenneth Tapia

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23385950

http://www.w3.org/2001/XMLSchema#string

P921

A' Cheinia

antiretroviral drug

P932

3737429

http://www.w3.org/2001/XMLSchema#string

Lipid changes in Kenyan HIV-1-infected infants initiating highly active antiretroviral therapy by 1 year of age

about

P2860

P2860

Lipid changes in Kenyan HIV-1-infected infants initiating highly active antiretroviral therapy by 1 year of age

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932